Welcome to CDC stacks | Browse Recent Additions
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Recent Additions
This page includes the documents that were newly added to the repository within the last 30 days.
421 - 440 of 1445 results
20 50 results
Sort By:
Sort By:
 
Small Close Icon
  • Date Added(Desc.) Selected Value
  • Date Added(Asc.)
  • Published Date(Asc.)
  • Published Date(Desc.)
  • Title (Asc.)
  • Title (Desc.)
  • Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending September 5, 2020 (Week 36) Table1e Botulism
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.
    Published Date:
    09/10/2020
    Series:
    National Notifiable Diseases: Infectious Weekly Tables 2020 week 36
    Description:
    2020-36-Table1e -H.pdf
    File Type:
    Filetype[PDF - 113.11 KB]
    Added:
    09/11/2020
  • Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending September 5, 2020 (Week 36) Table1d Arboviral diseases, neuroinvasive and non-neuroinvasive (continued); Babesiosis
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.
    Published Date:
    09/10/2020
    Series:
    National Notifiable Diseases: Infectious Weekly Tables 2020 week 36
    Description:
    2020-36-Table1d -H.pdf
    File Type:
    Filetype[PDF - 99.40 KB]
    Added:
    09/11/2020
  • Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending September 5, 2020 (Week 36) Table1c Arboviral diseases, neuroinvasive and non-neuroinvasive (continued)
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.
    Published Date:
    09/10/2020
    Series:
    National Notifiable Diseases: Infectious Weekly Tables 2020 week 36
    Description:
    2020-36-Table1c -H.pdf
    File Type:
    Filetype[PDF - 99.17 KB]
    Added:
    09/11/2020
  • Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending September 5, 2020 (Week 36) Table1b Arboviral diseases, neuroinvasive and non-neuroinvasive (continued)
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.
    Published Date:
    09/10/2020
    Series:
    National Notifiable Diseases: Infectious Weekly Tables 2020 week 36
    Description:
    2020-36-Table1b -H.pdf
    File Type:
    Filetype[PDF - 112.38 KB]
    Added:
    09/11/2020
  • Weekly cases of notifiable diseases, United States, U.S. territories, and Non-U.S. Residents weeks ending September 5, 2020 (Week 36) Table1a Anthrax; Arboviral diseases, neuroinvasive and non-neuroinvasive
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.
    Published Date:
    09/10/2020
    Series:
    National Notifiable Diseases: Infectious Weekly Tables 2020 week 36
    Description:
    2020-36-Table1a -H.pdf
    File Type:
    Filetype[PDF - 112.55 KB]
    Added:
    09/11/2020
  • COVID-19 vaccine prioritization : Work Group considerations
    Personal Author:
    Dooling, Kathleen
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2020 August 26 : Atlanta, GA)
    Published Date:
    August 26, 2020
    Series:
    ACIP meeting COVID-19 Vaccines
    Description:
    COVID-08-Dooling.pdf
    File Type:
    Filetype[PDF - 1.88 MB]
    Added:
    09/11/2020
  • COVID-19 vaccines : Work Group interpretation
    Personal Author:
    Oliver, Sara E.
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2020 August 26 : Atlanta, GA)
    Published Date:
    August 26, 2020
    Series:
    ACIP meeting COVID-19 Vaccines
    Description:
    COVID-07-Oliver.pdf
    File Type:
    Filetype[PDF - 1.59 MB]
    Added:
    09/11/2020
  • Modeling allocation strategies for the initial SARS-CoV-2 vaccine supply
    Personal Author:
    Slayton, Rachel B.
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2020 August 26 : Atlanta, GA)
    Published Date:
    August 26, 2020
    Series:
    ACIP meeting COVID-19 Vaccines
    Description:
    COVID-06-Slayton.pdf
    File Type:
    Filetype[PDF - 457.61 KB]
    Added:
    09/11/2020
  • Epidemiology of individuals at increased risk of COVID-19 disease
    Personal Author:
    McClung, Nancy
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2020 August 26 : Atlanta, GA)
    Published Date:
    August 26, 2020
    Series:
    ACIP meeting COVID-19 Vaccines
    Description:
    COVID-05-McLung.pdf
    File Type:
    Filetype[PDF - 2.19 MB]
    Added:
    09/11/2020
  • COVID-19 vaccine safety monitoring
    Personal Author:
    Shimabukuro, Tom T.
    Corporate Authors:
    CDC COVID-19 Vaccine Planning Unit. Vaccine Safety Team.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2020 August 26 : Atlanta, GA)
    Published Date:
    August 26, 2020
    Series:
    ACIP meeting COVID-19 Vaccines
    Description:
    COVID-04-Shimabukuro.pdf
    File Type:
    Filetype[PDF - 790.32 KB]
    Added:
    09/11/2020
  • mRNA-1273 cinical development program
    Personal Author:
    Miller, Jacqueline M.
    Corporate Authors:
    Moderna (firm)
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2020 August 26 : Atlanta, GA)
    Published Date:
    August 26, 2020
    Series:
    ACIP meeting COVID-19 Vaccines
    Description:
    COVID-02-Miller-508.pdf
    File Type:
    Filetype[PDF - 890.77 KB]
    Added:
    09/11/2020
  • ACIP COVID-19 Vaccines Work Group
    Personal Author:
    Bell, Beth P.
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2020 August 26 : Atlanta, GA)
    Published Date:
    August 26, 2020
    Series:
    ACIP meeting COVID-19 Vaccines
    Description:
    COVID-01-Bell.pdf
    File Type:
    Filetype[PDF - 775.29 KB]
    Added:
    09/11/2020
  • When you can be around others after you had or likely had COVID-19
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    Sept. 10, 2020
    Description:
    Updated Sept. 10, 2020If you have or think you might have COVID-19, it is important to stay home and away from other people. Staying away from others helps stop the spread of COVID-19. If you have an emergency warning sign (including trouble breathin...
    File Type:
    Filetype[PDF - 192.76 KB]
    Added:
    09/11/2020
  • Duration of isolation and precautions for adults with COVID-19
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    Sept. 10, 2020
    Description:
    Updated Sept. 10, 2020Accumulating evidence supports ending isolation and precautions for persons with COVID-19 using a symptom-based strategy. This update incorporates recent evidence to inform the duration of isolation and precautions recommended t...
    File Type:
    Filetype[PDF - 600.26 KB]
    Added:
    09/11/2020
  • COVID-19 pandemic planning scenarios
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    Sept. 10, 2020
    Description:
    Updated Sept. 10, 2020Updated September 10, 2020:• The Infection Fatality Ratio parameter has been updated to include age-specific estimates• The parameter for Number of Days from Symptom Onset to Seeking Outpatient Care—which was based on infl...
    File Type:
    Filetype[PDF - 238.58 KB]
    Added:
    09/11/2020
  • COVID-19 case surveillance public use data
    Corporate Authors:
    CDC Case Surveillance Task Force.
    Published Date:
    September 1, 2020
    Series:
    Data.CDC.gov
    Description:
    Updated: September 1, 2020Data Provided by: CDC Case Surveillance Task ForceThe COVID-19 case surveillance system database includes patient-level data reported to U.S. states and autonomous reporting entities, including New York City and the District...
    File Type:
    Filetype[PDF - 133.23 KB]
    Added:
    09/11/2020
  • What to do if your pet tests positive for the virus that causes COVID-19
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    Sept. 10, 2020
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    Updated Sept. 10, 2020What you need to know• If your pet tests positive for the virus that causes COVID-19, isolate the pet from everyone else, including other pets.• Do not wipe or bathe your pet with chemical disinfectants, alcohol, hydrogen pe...
    File Type:
    Filetype[PDF - 194.09 KB]
    Added:
    09/11/2020
  • Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19)
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    Sept. 10, 2020
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    Updated Sept. 10, 2020 : This interim guidance is for clinicians caring for patients with confirmed infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). CDC will updat...
    File Type:
    Filetype[PDF - 266.45 KB]
    Added:
    09/11/2020
  • Cleaning and disinfection for community facilities : interim recommendations for U.S. community facilities with suspected/confirmed coronavirus disease 2019 (COVID-19)
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    Sept. 10, 2020
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    Updated Sept. 10, 2020There is much to learn about the novel coronavirus (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19). Based on what is currently known about the virus and about similar coronaviruses that cause SARS and MERS, spread f...
    File Type:
    Filetype[PDF - 218.84 KB]
    Added:
    09/11/2020